Cisplatin-Ineligibility Flag for Pre-Surgery Bladder Cancer Referral

An EHR-embedded triage tool that screens every new muscle-invasive bladder cancer diagnosis for cisplatin ineligibility (renal function, hearing, neuropathy, performance status) and automatically refers flagged patients to medical oncology before cystectomy is scheduled — capturing the neoadjuvant window where the new enfortumab vedotin + pembrolizumab benefit was demonstrated.